We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.72B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Avg Time Held
5.7
years
Top 10 Avg Time Held
5
years
Top 20 Avg Time Held
5.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Splunk Inc
SPLK
|
+$164M |
| 2 |
Fidelity National Information Services
FIS
|
+$140M |
| 3 |
Intel
INTC
|
+$124M |
| 4 |
GSK
GSK
|
+$111M |
| 5 |
Mobileye
MBLY
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$753M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$370M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Charles Schwab
SCHW
|
+$197M |
| 5 |
Morgan Stanley
MS
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.17% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
DELISTED
Spirit Airlines, Inc.
SAVE
| $4.57M | ﹤0.01% |
234,800
-33,600
| -13% | -$689K |
2013 Q2
38 quarters
|
|
277
GrowGeneration
GRWG
$84.3M
| $4.55M | ﹤0.01% |
1,159,900
| – | – |
2022 Q1
3 quarters
|
|
278
Haleon
HLN
$44.5B
| $4.41M | ﹤0.01% |
551,400
| – | – |
2022 Q3
1 quarter
|
|
279
Knight Transportation
KNX
$10.5B
| $4.28M | ﹤0.01% |
+81,700
| New | +$4.22M |
2022 Q4
0 quarters
|
|
280
Boot Barn
BOOT
$3.69B
| $4.2M | ﹤0.01% |
67,100
-2,200
| -3% | -$132K |
2015 Q1
31 quarters
|
|
281
Five Below
FIVE
$12.3B
| $3.96M | ﹤0.01% |
22,400
| – | – |
2018 Q2
18 quarters
|
|
282
OraSure Technologies
OSUR
$249M
| $3.89M | ﹤0.01% |
807,720
-102,880
| -11% | -$472K |
2013 Q2
38 quarters
|
|
283
DELISTED
Immunogen Inc
IMGN
| $3.47M | ﹤0.01% |
700,227
-28,100
| -4% | -$152K |
2013 Q2
38 quarters
|
|
284
Ingevity
NGVT
$2.4B
| $3.45M | ﹤0.01% |
49,000
| – | – |
2017 Q4
20 quarters
|
|
285
JELD-WEN Holding
JELD
$120M
| $3.44M | ﹤0.01% |
356,600
+72,700
| +26% | +$705K |
2021 Q1
7 quarters
|
|
286
Comscore
SCOR
$51.9M
| $3.34M | ﹤0.01% |
144,172
-119,415
| -45% | -$3.09M |
2013 Q2
38 quarters
|
|
287
DELISTED
ZimVie
ZIMV
| $3.3M | ﹤0.01% |
353,337
-7,177
| -2% | -$62.7K |
2022 Q1
3 quarters
|
|
288
Grocery Outlet
GO
$1.28B
| $3.21M | ﹤0.01% |
110,000
-50,000
| -31% | -$1.57M |
2021 Q3
5 quarters
|
|
|
NUVA
289
DELISTED
NuVasive, Inc.
NUVA
| $3.06M | ﹤0.01% |
74,300
-58,600
| -44% | -$2.37M |
2013 Q2
38 quarters
|
|
290
Allegiant Air
ALGT
$1.83B
| $2.99M | ﹤0.01% |
44,050
| – | – |
2013 Q2
38 quarters
|
|
291
Gildan
GIL
$7.58B
| $2.72M | ﹤0.01% |
99,430
-4,570
| -4% | -$133K |
2014 Q2
34 quarters
|
|
292
Cboe Global Markets
CBOE
$32.9B
| $2.51M | ﹤0.01% |
20,000
-9,300
| -32% | -$1.15M |
2018 Q3
17 quarters
|
|
293
DELISTED
Sage Therapeutics
SAGE
| $2.46M | ﹤0.01% |
64,600
-13,200
| -17% | -$504K |
2021 Q4
4 quarters
|
|
294
Nokia
NOK
$51.2B
| $2.32M | ﹤0.01% |
500,000
| – | – |
2019 Q2
14 quarters
|
|
295
DELISTED
GAN Ltd
GAN
| $2.28M | ﹤0.01% |
1,519,285
-319,600
| -17% | -$538K |
2020 Q2
10 quarters
|
|
296
NN Inc
NNBR
$320M
| $2.25M | ﹤0.01% |
1,500,851
-696,149
| -32% | -$1.29M |
2014 Q1
35 quarters
|
|
297
Deckers Outdoor
DECK
$11.7B
| $2.24M | ﹤0.01% |
+33,600
| New | +$2.03M |
2022 Q4
0 quarters
|
|
298
WillScot Mobile Mini Holdings
WSC
$2.88B
| $2.19M | ﹤0.01% |
48,400
-20,600
| -30% | -$924K |
2018 Q3
17 quarters
|
|
299
DELISTED
Jamf
JAMF
| $2.07M | ﹤0.01% |
97,300
| – | – |
2021 Q2
6 quarters
|
|
300
Prestige Consumer Healthcare
PBH
$2.36B
| $1.97M | ﹤0.01% |
31,400
| – | – |
2017 Q4
20 quarters
|
|
Similar funds
Primecap Management's Q4 2022 Portfolio in Review
As of Q4 2022, Primecap Management held 343 positions worth $109B, up 5.7% from $103B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $3.72B in Q4 2022, closing 9 positions and reducing 229 holdings. Its most notable exit was Abiomed Inc, an estimated $370M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Mobileye worth $72.3M.
- Primecap Management's largest Q4 2022 buy was Mobileye: 2,061,470 shares worth $72.3M.
- Primecap Management added most to Splunk Inc in Q4 2022, an estimated $164M increase.
- Primecap Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $753M.
- Primecap Management fully exited Abiomed Inc in Q4 2022, selling an estimated $370M.
- Primecap Management's ten largest holdings make up 33% of its $109B portfolio in Q4 2022.
- Primecap Management opened 8 new positions and closed 9 in Q4 2022.
- Primecap Management's portfolio value rose 5.7% quarter-over-quarter to $109B.
Based on Primecap Management's 13F filing for Q4 2022, filed 13 Feb 2023.